Help For Ragweed Allergy

Thursday, 17 Apr 2014 04:02 PM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink
The U.S. Food and Drug Administration has approved Merck & Co's pollen allergy drug Ragwitek.

The tablet, which is administered by placing it under the tongue, is to treat the short ragweed pollen induced allergic rhinitis.

The approval for Ragwitek comes days after U.S. regulatory approval for Merck's grass pollen allergy drug Grastek.

Merck's Ragwitek will compete with Stallergenes SA's immunotherapy treatment for five types of grass pollen, which was approved by the FDA earlier this month.

© 2014 Thomson/Reuters. All rights reserved.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

FDA OKs Once-a-Week Diabetes Drug

Friday, 19 Sep 2014 12:36 PM

FDA OKs Once-a-Week Diabetes DrugOnce-a-Week Diabetes DrugThe U.S. Food and Drug Administration approved a new type 2 di . . .

Once-a-Week Diabetes Drug

Friday, 19 Sep 2014 12:34 PM

The U.S. Food and Drug Administration approved a new type 2 diabetes drug, Trulicity, on Thursday. Trulicity is part of  . . .

Fast-Acting Erectile Dysfunction Pill

Thursday, 18 Sep 2014 08:26 AM

An erectile dysfunction drug that reduces by half the time patients need to take the pill before sexual activity has bee . . .

Most Commented

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved